Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1998 Apr 28;95(9):4847–4852. doi: 10.1073/pnas.95.9.4847

Crystal structure of troponin C in complex with troponin I fragment at 2.3-Å resolution

Dmitry G Vassylyev *, Soichi Takeda *, Soichi Wakatsuki , Kayo Maeda *, Yuichiro Maéda *,
PMCID: PMC20176  PMID: 9560191

Abstract

Troponin (Tn), the complex of three subunits (TnC, TnI, and TnT), plays a key role in Ca2+-dependent regulation of muscle contraction. To elucidate the interactions between the Tn subunits and the conformation of TnC in the Tn complex, we have determined the crystal structure of TnC (two Ca2+ bound state) in complex with the N-terminal fragment of TnI (TnI1–47). The structure was solved by the single isomorphous replacement method in combination with multiple wavelength anomalous dispersion data. The refinement converged to a crystallographic R factor of 22.2% (Rfree = 32.6%). The central, connecting α-helix observed in the structure of uncomplexed TnC (TnCfree) is unwound at the center (residues Ala-87, Lys-88, Gly-89, Lys-90, and Ser-91) and bent by 90°. As a result, TnC in the complex has a compact globular shape with direct interactions between the N- and C-terminal lobes, in contrast to the elongated dumb-bell shaped molecule of uncomplexed TnC. The 31-residue long TnI1–47 α-helix stretches on the surface of TnC and stabilizes its compact conformation by multiple contacts with both TnC lobes. The amphiphilic C-end of the TnI1–47 α-helix is bound in the hydrophobic pocket of the TnC C-lobe through 38 van der Waals interactions. The results indicate the major difference between Ca2+ receptors integrated with the other proteins (TnC in Tn) and isolated in the cytosol (calmodulin). The TnC/TnI1–47 structure implies a mechanism of how Tn regulates the muscle contraction and suggests a unique α-helical regulatory TnI segment, which binds to the N-lobe of TnC in its Ca2+ bound conformation.


The regulation of skeletal and cardiac muscle contraction is associated with a Ca2+-dependent structural transition in the muscle thin filament—the complex of actin, tropomyosin, and troponin (Tn) (13). The signals induced by the variations of the Ca2+ concentration are transferred to the other components of the thin filament through the Ca2+ receptor, Tn (4, 5). Tn consists of three distinct subunits: TnC, TnI, and TnT. TnC is the Ca2+-binding subunit. TnT binds to tropomyosin, and thereby anchors Tn to the muscle thin filament. The binding of Ca2+ to TnC facilitates the release of inhibitory segment of TnI from the actin molecule, thus triggering the actomyosin Mg2+-ATPase (68). This process is regulated by TnC in a Ca2+-dependent manner. At the binding of Ca2+, the N-lobe of TnC undergoes a structural transformation from the “closed” state to the “open” Ca2+-bound form (911). These alterations of the TnC N-lobe facilitate the release of the regulatory region of TnI from the thin filament binding site and ensure its preferential binding to TnC, which relieves the inhibition of the actomyosin Mg2+-ATPase.

The crystal structure of TnCfree, determined at an acidic pH (5.0), revealed a dumb-bell shaped molecule that consists of two N- and C-terminal lobes (N- and C-lobes) connected by a long central α-helix (12, 13). Each lobe has two Ca2+-binding helix–turn–helix motifs, known as EF-hands. Under physiological conditions, the EF-hands in the C-lobe always are occupied by Ca2+ or Mg2+, whereas the N-lobe has lower affinity for Ca2+, and its EF-hands can be filled with Ca2+ only at the release of Ca2+ into the sarcoplasm. Thus, it now is believed that the C-lobe plays a structural role in TnC, whereas the N-lobe is directly involved in the regulation of muscle contraction.

Although the structure of TnCfree has been known for more than a decade, its conformation within Tn, as well as the structural mechanism of how TnC regulates the actomyosin Mg2+-ATPase activity, remains obscure. To elucidate the functional role and the conformation of TnC in Tn, we have determined the crystal structure of TnC in complex with TnI1–47.

MATERIALS AND METHODS

Protein Preparation and Crystallization.

In the present study, to avoid N-terminal heterogeneity, TnC was expressed by using pMal-c2 (New England Biolabs) as a fusion protein, which was cleaved by factor Xa after purification. The recombinant TnC molecule used in the present work has an extra Met residue at the N terminus, which is not in the peptide sequence of the rabbit skeletal muscle TnC (SWISS-PROT entry P02586). Therefore, in this report, this Met is omitted from the numbering of the TnC amino acid residues. The sequence of rabbit TnC was aligned with the chicken TnC sequence (91% of homology), used for the comparison in the present study, so that the rabbit amino acid with number N corresponds to the residue numbered (N+3) in the chicken sequence. The TnC/TnI1–47 complex was prepared and crystallized as described previously, with minor modifications (14). It was found that the nonisomorphism between the native and heavy atom derivative crystals (14) is not induced by the heavy atom soaking, but should be addressed to the nonisomorphism of different native crystals. The crystals used in this study belong to the space group P3221, with the unit cell dimensions a = b = 46.9 Å, c = 152.3 Å, and with a solvent content of 35%.

Data Collection.

The data for the native TnC/TnI1–47 complex and its PCMBS (p-chloro-mercuribenzenesulfonate) derivative at three distinct wave lengths (including one at the absorption edge of the Hg atom) have been collected from the two single frozen crystals (100K) at beam line BM14 (European Synchrotron Radiation Facility, Grenoble). The PCMBS derivative crystal diffracted to only 2.8-Å resolution. The diffraction data were processed with the programs denzo and scalepack (15) (Table 1). Judging by the unit cell dimensions, the native and PCMBS derivative crystals were isomorphous to each other.

Table 1.

Summary of the TnC/TnI1-47 complex structure determination

Data collection Native PCMBS derivative
λ1 (1.00866 Å) λ2 (1.00395 Å) λ3 (0.95373 Å)
Resolution (Å) 25.0-2.3 25.0-2.8 25.0-2.8 25.0-2.8
Reflections
 Total (N) 37,214 22,050 21,747 23,003
 Unique (N)  8,870  4,998  4.989  5,091
Rsym* (%) 5.0  5.3  6.0  5.1
 Completeness (%) 96.3 (82.0) 94.1 94.4 94.8
Riso (%) 22.2 23.2 24.0
 Phasing power§  3.0  3.1  3.0
Refinement statistics   Stereochemistry
 Resolution (Å)10.0-2.3 Å    RMSD bond length (Å)0.01  
 Number of reflections8,736    RMSD bond angles (°)1.28  
Rcryst (%)22.2    RMSD improper angles (°)0.72  
Rfree (%)32.5
 Number of protein atoms1,502
 Number of water molecules89
 Number of calcium ions2
*

Rsym = ∑hklj | Ij (hkl) − < I (hkl) > |/∑hklj | < I (hkl) >, where Ij (hkl) and < I (hkl) > are the intensity of measurement j and the mean intensity for the reflection with indices hkl, respectively. 

The completeness of reflections with I > 3σ(I) is shown in brackets. 

Riso = ∑hkl || Fder(hkl) | − | Fnati (hkl)|| / ∑hkl | Fnati (hkl) |, where Fder (hkl) and Fnati (hkl) are the structure factors of the heavy atom derivative and the native for the reflection with indices hkl, respectively. 

§

Phasing power = < Fh >/E, where <Fh> is the root mean square heavy-atom structure factor and E is the residual lack of closure error. 

Rcryst,free = ∑hkl || Fcalc (hkl) | − | Fobs (hkl) ||/∑hkl | Fobs |, where the crystallographic R factor is calculated including and excluding the refinement reflections. The free reflections constituted 7% of the total number of reflections. 

Structure Determination.

All initial attempts to determine the TnC/TnI1–47 structure by molecular replacement by using the programs amore (16) and x-plor (17), and the structure of uncomplexed TnC, as either a whole or its lobes, failed. The structure was solved by using the single isomorphous replacement (SIR) method in combination with the multiple wavelength anomalous dispersion (MAD) technique. The major heavy atom site of the PCMBS derivative was located in both isomorphous and anomalous difference Patterson maps with the rsps program (16). The heavy atom site was refined by using the mlphare program (18) modified by D.G.V. (unpublished work), and three additional minor heavy atom sites were found in the difference Fourier maps. The overall figure of merit was 0.85 at 2.8-Å resolution. The SIR/MAD electron density map then was calculated, and the phases were improved by solvent flattening and histogram matching using the dm program (16). The rough orientation of the TnC lobes (Protein Data Bank entry 1TOP) in the final electron density map was determined manually by using the o program (19). The TnC model then was rebuilt to achieve the best fit to the electron density, and the interlobe linker region and the TnI1–47 α-helix were modeled with the o program.

Refinement.

The data in the 25- to 10-Å shell were omitted from the refinement because this shell contains a substantial number of overloaded intensities. The R factor for the initial model was 48%. The model was refined with the program x-plor (17) (Table 1). During the course of refinement, the fraction of residues in the most favorable region of the Ramachandran plot increased from 80% to 88.3%, as indicated by the program procheck (20). No residues were found in the disallowed region of the Ramachandran plot. The average B factor of the final model is 43 Å2. Almost all of the modeled residues, including their side chains, are well defined by the electron densities in the final (2Fo-Fc) map.

RESULTS AND DISCUSSION

Structure Determination.

The crystal structure of the complex between rabbit skeletal muscle TnC (160 residues, 18 kDa) and TnI1–47 has been solved by the single isomorphous replacement/multiple wavelength anomalous dispersion technique (Table 1). The refinement converged to an R factor of 22.2% (Rfree = 32.6%) at 2.3-Å resolution (Table 1). The final model lacks two N-terminal residues of TnC, and two and 14 amino acids from the N- and C-termini of TnI1–47, respectively, probably because these residues are disordered in the crystal.

Structure Description.

The conformation of TnC in the TnC/TnI1–47 complex is strikingly different from that of TnCfree, in which the two lobes are connected by a long α-helix, and thus, the length of the molecule is about 65 Å (12, 13). In the complex, this connecting D/E α-helix is unwound at the center and is transformed into an extended linker between the two TnC lobes. The residues Ala-87, Lys-88, Gly-89, Lys-90, and Ser-91 constitute the linker with the main chain (φ, ψ) torsion angles, (−79, 179), (−69, 159), (−92, −171), (−147, 41), and (−50, 146), respectively. All the residues in the linker are well defined by the electron densities, except for the side chain of Lys-88, and their average B factor (45 Å2) is very close to the overall average value (43 Å2). The 120° rotation, indicated by the program lsqkab (16), of the TnC lobes relative to their orientation in the TnCfree accompanies the unwinding of the D/E α-helix, which results in a 90° kink (inclination between the two helical axes) between its D- and E-portions. As a result of these alterations, the TnC molecule in the TnC/TnI1–47 complex has a compact globular shape, with approximate dimensions of 50 × 30 × 30 Å (Fig. 1A). The N- and C-lobes come into close proximity and form a deep narrow interlobe cleft. There are two direct interlobe hydrogen bonds in TnC within the TnC/TnI1–47 complex. Only two Ca2+-binding sites (EF-hands) in the C-lobe of TnC in the complex are occupied by Ca2+, whereas the two other EF-hands in the N-lobe are empty (Fig. 1A), as was observed in the TnCfree structure. Thus, the conformation of each TnC lobe itself in the TnC/TnI1–47 complex is very similar to that in the TnCfree structure. The rms deviations between all Cα atoms of TnCfree and TnC in the TnC/TnI1–47 complex are 1.0 Å and 1.2 Å for the N- (residues 2–86) and C-lobes (residues 92–159), respectively. Among these, four C-terminal residues exhibit largest rms deviations of 6.5 Å. In the TnC/TnI1–47 complex, these residues are moved into a close proximity with TnI1–47 α-helix.

Figure 1.

Figure 1

Structure of the TnC/TnI1–47 complex. (A) Ribbon diagram of the TnC/TnI1–47 complex structure. The α-helices, β-strands, and loops of TnC are in red, green, and yellow, respectively. The unwound and kinked central D/E α-helix of TnC is shown in blue, and the interdomain extended linker is black. The two calcium ions in the TnC C-lobe are shown as black balls. The TnI1–47 α-helix is in cyan. The figure was drawn with the molscript program (21). (B) Hydrophobic (green arrows) and polar (red arrows) side-chain interactions between TnI1–47 (circles) and TnC (rectangles) residues in the TnC/TnI1–47 complex. The hydrophobic and polar residues are shown in green and red, respectively. Water molecules are shown as cyan hexagons. Main chain carbonyl oxygens of the interacting amino acids are shown as a red O attached to the subsequent residues. (C) Portion of the final (2Fo-Fc) electron density map and the TnC/TnI1–47 model (ball and stick) in the hydrophobic cavity of the C-lobe of TnC. The TnI and TnC residues are shown in cyan and atom-dependent (C, N, O, and S are yellow, blue, red, and green, respectively) colors, respectively. Met-21, protruding into hydrophobic cleft of TnC, is colored red. The figure was produced with the o program (19).

The TnI1–47 fragment in the TnC/TnI1–47 complex contains a 31-residue long α-helix that is slightly bent toward the concave surface of the TnC molecule (Fig. 1A). Fourteen residues at the C-end of TnI1–47 are disordered in the crystal, and probably do not have contacts with TnC. The TnI1–47 α-helix makes multiple polar and van der Waals interactions with both lobes of TnC. According to these interactions, the TnI1–47 α-helix may be divided into two parts. The N-terminal (residues 3–12) and C-terminal (residues 13–33) portions of this α-helix are bound to the N- and C-lobes of TnC, respectively. Arg-14 of TnI1–47 is located at the interface between the lobes of TnC and bridges them by four strong hydrogen bonds (Fig. 1B). The C-terminal part of the TnI α-helix is tightly bound to the C-lobe of TnC by 11 hydrogen bonds. In addition, there are 38 van der Waals interactions (<4 Å) between the amphiphilic C-end of TnI1–47 α-helix and the TnC residues in the hydrophobic pocket of the C-lobe (Fig. 1B). Thus, the hydrophobic residues of TnI1–47 and TnC complement each other and constitute the hydrophobic core of the TnC/TnI1–47 complex. We believe that these hydrophobic interactions play a major role in the recognition between TnC and TnI1–47. It is worthwhile to mention that Met-21 of TnI1–47 seems to be of central importance for the recognition; its bulky side chain protrudes deeply into the hydrophobic cavity of the TnC C-lobe and makes a total of eight van der Waals contacts with the TnC residues (Fig. 1 B and C). Judging by the crystal structure, the interactions of TnI1–47 with the N-lobe of TnC seem to be weaker than those with the C-lobe. There are only four direct and three water-mediated hydrogen bonds (Fig. 1B). It is likely that these interactions are required mostly to anchor the TnC N-lobe to TnI, to stabilize the compact conformation of TnC, and do not play an essential role in recognition.

Comparison with Calmodulin.

The overall conformation of TnC and the rearrangement of the TnC lobes induced by TnC/TnI1–47 complex formation resemble another Ca2+-receptor protein, calmodulin, in the complexes with its target peptides (22, 23). The extended dumb-bell shaped molecules of both proteins undergo substantial conformational changes on binding to other proteins. In both cases, the dramatic reorientation of the lobes accompanies the unwinding and the kink of the central connecting α-helix, resulting in the compact globular protein structure. Moreover, the target peptides of both proteins adopt α-helical conformations, and the recognition mechanism involves multiple hydrophobic interactions between the proteins and the amphiphilic portions of the bound peptides. The latter feature also resembles the binding between the myosin light and heavy chains (24). However, there is an essential difference between TnC and calmodulin (myosin light chain) in the mode of binding to the substrates. In the calmodulin/peptide complexes, the hydrophobic binding sites of both lobes are turned toward each other and toward the center of the molecule. This orientation allows both lobes of calmodulin to interact simultaneously with two regions of the same target α-helix. In contrast, in the TnC/TnI1–47 complex, the hydrophobic pockets in the C- and N-lobes are turned out of the molecular center and are located on opposite sides of the molecular surface. If TnC in the functional Tn adopts the conformation observed in the TnC/TnI1–47 complex, the binding of a single α-helix to both lobes of TnC, as in the calmodulin complexes, is impossible.

Regulatory Segment of TnI.

The understanding of how the inhibition of acto-myosin ATPase is released is of central importance in the studies of mechanism of regulation of muscle contraction. Therefore, in the past years many biochemical and biophysical studies were focused on the inhibitory segment (residues 96–116) of TnI (5, 25). The inhibitory segment was shown to bind to either actin-tropomyosin or TnC, thus switching on and off the acto-myosin ATPase activity (68). On the other hand, the conformational changes between “closed” and “open” forms of TnC regulatory N-lobe induced by Ca2+ binding also entail the regulation of muscle contraction. The C- and N-lobes of TnC are very similar in both sequence and structure in the Ca2+-bound states (911, 26). Thus, the TnC/TnI1–47 structure suggests that “open” N-lobe of TnC would bind to another amphiphilic α-helix in a symmetrical manner. In view of important regulatory role of TnI inhibitory segment, it is likely that this α-helix is located in the vicinity of the inhibitory peptide in TnI. Indeed, such a hydrophobic segment exists at the C-end of the TnI inhibitory sequence and was predicted to have an α-helical conformation (27). This region is highly conserved among TnIs from different species. The N-terminal and “inhibitory” sequences are similar in the general hydrophobicity of the amino acids, although the sequence identity is low (Fig. 2). However, the methionine residue (Met-121), corresponding to the N-terminal Met-21, which was proposed to play an important role in the recognition between TnC and TnI1–47, is conserved in the “inhibitory” sequence (Fig. 2). The measurements of the binding constants of two TnI inhibitory fragments to TnC showed that TnI96–116 preferably interacts with the C-lobe of TnC, whereas its C-terminal extension, TnI96–148, is most tightly bound to the TnC N-lobe (27). At a high Ca2+ concentration, the segment at the C-end of the TnI inhibitory sequence was protected against proteolysis (28) and was proved to be crucial for the regulatory activity of Tn (29). Taken together, the biochemical data and our hypothesis strongly suggest that the TnI inhibitory region could be extended to the regulatory TnI fragment (TnIreg, residues 96–127 of TnI) (Fig. 2), in which the amphiphilic C-end (residues 117–127) would play the major regulatory role in the relief of the inhibition of the actomyosin Mg2+-ATPase, through binding to the hydrophobic pocket of the TnC N-lobe in its “open” state.

Figure 2.

Figure 2

TnI sequence at the C-end (residues 117–127, rabbit skeletal muscle) of the inhibitory fragment (residues 96–116) aligned with the amphiphilic portion of TnI1–47. The identical residues are red, the distinct residues are black, and the amphiphilic residues corresponding to the hydrophobic amino acids are green.

Model Building of TnIreg.

The three-dimensional model of the TnC/TnIreg complex (Fig. 3A) was constructed in four steps. First, the “closed” N-lobe of TnC in the TnC/TnI1–47 complex was replaced by a Ca2+ bound, “open” N-lobe (Protein Data Bank entry 1TNQ) (26). Second, the C-lobe bound to the TnI1–47 α-helix was superimposed on the “open” N-lobe, and the resulting orientation of the α-helix was taken as a starting model for TnIreg. Third, the TnI1–47 sequence was replaced by that of TnIreg in the model. At this stage, the conserved Met-121 of TnIreg fits very well into the hydrophobic cleft of the N-lobe of TnC (Fig. 3B). Finally, a two-proline kink (residues 109–110) was introduced in the TnIreg α-helix, on the basis of an NMR structure of the inhibitory peptide (residues 104–115) bound to TnC (30) (Table 2). In addition, the N-end of the α-helix was extended to the TnI residue 96 to make it more consistent with the biochemical data. The model was then refined by energy minimization with the x-plor program (17). At the high Ca2+-concentration, the distances between Trp-106 (TnI) and Met-25, Cys-89 (TnC) are 21.6 Å and 20.2 Å, respectively, which are in good agreement with the respective distances of 24.2 Å and 23.2 Å measured from the proposed model of the TnIreg bound to open TnC N-domain (X. Zhao, T. Kobayashi, H. Malak, I. Gryczynski, J. Lakowicz, R. Wade, and J. H. Collins, personal communication).

Figure 3.

Figure 3

TnC/TnIreg model structure. The figure was prepared by using molscript (21). (A) Ribbon diagram of the TnC/TnI1–47/TnIreg model. The two “open” N- and C-lobes of TnC are green and red, respectively. Four calcium ions are shown as black balls. The TnI1–47 and TnIreg α-helices are shown in cyan and yellow, respectively. The two-proline linker (Pro-109 and Pro-110) in the TnIreg α-helix is shown in blue. (B) Stereo view of the hydrophobic core of the TnC/TnIreg model structure. The TnC and TnIreg α-helices are shown in blue and yellow, respectively. The side chains of the residues in the hydrophobic pocket of the “open” C-lobe of TnC and the complementary hydrophobic residues of TnIreg (ball and stick) are cyan and green, respectively. Protruding side chain of Met-121 is shown in red.

Table 2.

Comparison of the TnC/TnIreg model with NMR structure of TnI inhibitory peptide (residues 104-116) bound to TnC

Residue (TnI) Main chain torsion angles (φ, ψ)
NMR structure TnC/TnIreg model
φ(°) ψ(°) φ(°) ψ(°)
Lys-107 −70 −25 −66 −25
Arg-108 −59 −38 −44 −34
Pro-109 −80 174 −58 149
Pro-110 −78 161 −89 152
Leu-111 −59 −23 −56 −26
Arg-112 −66 −43 −55 −38

The TnIreg model could be divided into two parts; the N-terminal part (residues 96–107) is likely to interact with the C-lobe of TnC, whereas the C-terminal region (residues 108–127) is strongly bound to the TnC N-lobe (Fig. 3A). In the TnC/TnIreg model, seven hydrophobic residues at the C-terminal region of TnIreg are likely to interact with the 13 TnC residues in the hydrophobic cavity of the N-lobe (Fig. 3B). Interestingly, according to our model, Phe-100 of TnIreg may form multiple hydrophobic contacts with Phe-148 and Leu-152 of TnC, which would increase the affinity of TnIreg to the TnC C-lobe.

Implications for the Regulation of Muscle Contraction.

The TnC/TnIreg model suggests the possible mechanism of regulation of muscle contraction by Tn complex. At the binding of Ca2+ the conformation of regulatory N-lobe of TnC will be changed from the “closed” to “open” state. This structural transformation of TnC probably would facilitate the relief of inhibition of acto-myosin ATPase by TnIreg. Thus, TnIreg preferably would bind to TnC, and its amphiphilic C-end would be locked in the hydrophobic cavity of TnC N-lobe through the multiple van der Waals interactions. The release of Ca2+ from N-lobe of TnC would initiate its transformation to the “closed” form, which would push the amphiphilic α-helix of TnIreg out of the pocket. After “closing” of TnC N-lobe this hydrophobic α-helix could not bind on the surface of TnC covered by hydrophilic residues. Thus, the amphiphilic TnIreg α-helix would be able to bind to some putative hydrophobic site in the actin molecule, which increases the affinity of TnIreg to actin, and facilitates its release from TnC and the binding to actin-tropomyosin.

CONCLUSIONS

The TnC/TnI1–47 complex structure and the TnC/TnIreg model provide several important implications. (i) Within Tn, the TnC molecule has a compact globular shape with direct polar interactions between the N- and C-lobes. (ii) The N-terminal region of TnI and TnIreg have α-helical structures and are bound to TnC in a pseudo-symmetrical manner. (iii) The recognition of TnI1–47 and TnIreg by TnC is accomplished by hydrophobic interactions, in which Met-21 (TnI1–47) and Met-121 (TnIreg) are probably the key residues. (iv) TnIreg binds to both lobes of TnC in the presence of Ca2+, and hence, it alone may induce the functional, compact conformation of TnC. Consistent with this, an N-terminal deletion mutant, TnI58–182, still can constitute a functional Tn, but only at high Ca2+ concentrations (31). (v) The two-proline kink in the TnIreg α-helix probably is required to direct the N-end of TnIreg toward the TnC C-lobe. (vi) The difference between calmodulin and TnC in the binding to their targets accounts for their distinct biological functions. Calmodulin functions as an isolated protein; thus, both of its lobes are involved in signal transduction. In contrast, TnC is integrated into the Tn complex through its C-lobe, and only the N-lobe possesses regulatory activity.

In conclusion, the binding of TnI1–47 to the TnC C-lobe is likely to play a primarily structural role in the formation of Tn, whereas the amphiphilic C-end of TnIreg forms the actual switch that moves between actin-tropomyosin and the hydrophobic cleft of the N-lobe of TnC in a Ca2+-dependent manner, thereby regulating the process of muscle contraction.

Acknowledgments

We thank Yumiko Saijo for preparing the crystals, A. Thompson, V. Stojanoff, and M. Yao for help at the beam-line BM14, K. Imada for help using the laboratory x-ray system, and J.H. Collins for letting us refer to unpublished results. We are grateful to I. Ohtsuki, S. Cusack, and Susan Tsutakawa for reviewing the manuscript before submission, and to F. Oosawa, S. Ebashi, and T. Nitta for helpful discussions and encouragement.

ABBREVIATIONS

TN

troponin

PCMBS

p-chloro-mercuribenzenesulfonate

Footnotes

Data deposition: Crystallographic data (coordinates and structure factors) have been deposited at the Protein Data Bank, Biology Department, Brookhaven National Laboratory, Upton, NY 11973 (entry 1A2X).

References

  • 1.Ebashi S, Endo M. Prog Biophys Mol Biol. 1968;18:123–183. doi: 10.1016/0079-6107(68)90023-0. [DOI] [PubMed] [Google Scholar]
  • 2.Ebashi S, Endo M, Ohtsuki I. Q Rev Biophys. 1969;2:351–384. doi: 10.1017/s0033583500001190. [DOI] [PubMed] [Google Scholar]
  • 3.Lehrer S S. J Muscle Res Cell Motil. 1994;15:232–236. doi: 10.1007/BF00123476. [DOI] [PubMed] [Google Scholar]
  • 4.Ohtsuki I, Maruyama K, Ebashi S. Adv Protein Chem. 1986;38:1–67. doi: 10.1016/s0065-3233(08)60525-2. [DOI] [PubMed] [Google Scholar]
  • 5.Zot A S, Potter J D. Annu Rev Biophys Biophys Chem. 1987;16:535–559. doi: 10.1146/annurev.bb.16.060187.002535. [DOI] [PubMed] [Google Scholar]
  • 6.Potter J D, Gergely J. Biochemistry. 1974;13:2697–2703. doi: 10.1021/bi00710a007. [DOI] [PubMed] [Google Scholar]
  • 7.Tao T, Gong B J, Leavis P C. Science. 1990;247:1339–1341. doi: 10.1126/science.2138356. [DOI] [PubMed] [Google Scholar]
  • 8.Miki M. Eur J Biochem. 1990;187:155–162. doi: 10.1111/j.1432-1033.1990.tb15289.x. [DOI] [PubMed] [Google Scholar]
  • 9.Herzberg O, Moult J, James M N. J Biol Chem. 1986;261:2638–2644. [PubMed] [Google Scholar]
  • 10.Strynadka N C, Cherney M, Sielecki A R, Li M X, Smillie L B, James M N. J Mol Biol. 1997;273:238–255. doi: 10.1006/jmbi.1997.1257. [DOI] [PubMed] [Google Scholar]
  • 11.Houdusse A, Love M L, Dominguez R, Grabarek Z, Cohen C. Structure. 1997;5:1695–1711. doi: 10.1016/s0969-2126(97)00315-8. [DOI] [PubMed] [Google Scholar]
  • 12.Herzberg O, James M N. Nature (London) 1985;313:653–659. doi: 10.1038/313653a0. [DOI] [PubMed] [Google Scholar]
  • 13.Sundaralingam M, Bergstrom R, Strasburg G, Rao S T, Roychowdhury P, Greaser M, Wang B C. Science. 1985;227:945–948. doi: 10.1126/science.3969570. [DOI] [PubMed] [Google Scholar]
  • 14.Saijo Y, Takeda S, Scherer A, Kobayashi T, Maéda Y, Taniguchi H, Yao M, Wakatsuki S. Protein Sci. 1997;6:916–918. doi: 10.1002/pro.5560060420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Otwinowski Z, Minor W. In: Methods in Enzymology. Carter C W J, Sweet R M, editors. San Diego: Academic; 1997. pp. 307–326. [DOI] [PubMed] [Google Scholar]
  • 16.Collaborative Computational Project No 4. Acta Crystallogr D. 1994;50:760–763. [Google Scholar]
  • 17.Brünger A. x-plor Version 3.1 Manual. New Haven: Yale Univ. Press; 1992. [Google Scholar]
  • 18.Otwinowski Z. In: Proceedings of the CCP4 Study Weekend. Sawyer N I L, Borley S, editors. Daresbury, U.K.: SERC Daresbury; 1993. pp. 56–62. [Google Scholar]
  • 19.Jones T A, Zou J Y, Cowan S E, Kjeldgaard M. Acta Crystallogr A. 1991;47:110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  • 20.Laskowski R A, MacArthur M W, Moss D S, Thornton J M. J Appl Cryst. 1993;26:283–291. [Google Scholar]
  • 21.Kraulis P J. J Appl Cryst. 1991;24:946–950. [Google Scholar]
  • 22.Ikura M, Clore G M, Gronenborn A M, Zhu G, Klee C B, Bax A. Science. 1992;256:632–638. doi: 10.1126/science.1585175. [DOI] [PubMed] [Google Scholar]
  • 23.Meador W E, Means A R, Quiocho F A. Science. 1993;262:1718–1721. doi: 10.1126/science.8259515. [DOI] [PubMed] [Google Scholar]
  • 24.Xie X, Harrison D H, Schlichting I, Sweet R M, Kalabokis V N, Szent-Gyorgyi A G, Cohen C. Nature (London) 1994;368:306–312. doi: 10.1038/368306a0. [DOI] [PubMed] [Google Scholar]
  • 25.Farah C S, Reinach F C. FASEB J. 1995;9:755–767. doi: 10.1096/fasebj.9.9.7601340. [DOI] [PubMed] [Google Scholar]
  • 26.Gagne S M, Tsuda S, Li M X, Smillie L B, Sykes B D. Nat Struct Biol. 1995;2:784–789. doi: 10.1038/nsb0995-784. [DOI] [PubMed] [Google Scholar]
  • 27.Pearlstone J R, Sykes B D, Smillie L B. Biochemistry. 1997;36:7601–7606. doi: 10.1021/bi970200w. [DOI] [PubMed] [Google Scholar]
  • 28.Takeda S, Kobayashi T, Taniguchi H, Hayashi H, Maéda Y. Eur J Biochem. 1997;246:611–617. doi: 10.1111/j.1432-1033.1997.00611.x. [DOI] [PubMed] [Google Scholar]
  • 29.Farah C S, Miyamoto C A, Ramos C H, da Silva A C, Quaggio R B, Fujimori K, Smillie L B, Reinach F C. J Biol Chem. 1994;269:5230–5240. [PubMed] [Google Scholar]
  • 30.Campbell A P, Sykes B D. J Mol Biol. 1991;222:405–421. doi: 10.1016/0022-2836(91)90219-v. [DOI] [PubMed] [Google Scholar]
  • 31.Potter J D, Sheng Z, Pan B-S, Zhao J. J Biol Chem. 1995;270:2557–2562. doi: 10.1074/jbc.270.6.2557. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES